Evidence map›Paper›PMID 30719997›Full record

ArticleEndoscopic ultrasound

Discontinuation of proton pump inhibitor use reduces the number of endoscopic procedures required for resolution of walled-off pancreatic necrosis.

Patrick C Powers, Ali Siddiqui, Reem Z Sharaiha, Grace Yang, Enad Dawod, Aleksey A Novikov, Amy Javia, Cynthia Edirisuriya, Arish Noor, Tayebah Mumtaz and 9 more

Registry-linked trialAbstract read
In one paragraph

Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05817721 (PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05817721 completednot on this map

PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents (PROTOCOL)

TypeobservationalSponsorUniversity Medical Center GoettingenRan2023 to 2024Enrolled893ConditionsAcute PancreatitisArmsProton pump inhibitor, LAMS-implantation
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Infected pancreatic necrosis-Current trends in management.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2024
    Review
  7. Review
  8. Review
  9. Review
  10. Time to think prime times for treatment of necrotizing pancreatitis: Pendulum conundrum.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2023
    Review
  11. Endoscopic therapies for walled-off necrosis.iGIE : innovation, investigation and insights · 2023
    Article
  12. Review
  13. Review
  14. Endoscopic step up: When and how.Surgery open science · 2022
    Article
  15. Review
  16. Management of pancreatic fluid collections.Translational gastroenterology and hepatology · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Patrick C PowersDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Utah, Salt Lake City, UT, USA.
Ali SiddiquiDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
Reem Z SharaihaDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Grace YangDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
Enad DawodDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Aleksey A NovikovDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Amy JaviaDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
Cynthia EdirisuriyaDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
Arish NoorDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
Tayebah MumtazDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
Usama IqbalDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
David E LorenDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
Thomas E KowalskiDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
Natalie CosgroveDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA, USA.
Yordano AliceaDepartment of Internal Medicine, Drexel University, Philadelphia, PA, USA.
Amy TybergDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Iman AndalibDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Michel KahalehDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Douglas G AdlerDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Utah, Salt Lake City, UT, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesEndoscopic drainage/debridement of symptomatic walled off necrosis (WON) using lumen-apposing metal stents (LAMS) is both safe and effective. While endoscopic management of WON is the standard approach to treatment, the ideal concomitant medical therapy remains unclear. The purpose of this study was to further elucidate the effect of proton pump inhibitor (PPIs) therapy on the technical and clinical success of endoscopic treatment of WON.

methodsTwo hundred and seventy-two patients in 8 centers with WON managed by endoscopic drainage using LAMS were evaluated. Patients were followed for at least 6 months following treatment. The patients were divided into two groups: Those that used PPIs continuously during the therapy and those not on PPIs continuously during the interval of therapy. Outcomes included but were not limited to technical success, clinical success, number of procedures performed, and adverse events.

resultsFrom 2013 to 2016, 272 patients underwent WON drainage with successful transmural LAMS placement. The two groups were split evenly into PPI users and non-PPI users, and matched in regards to demographics, etiology of pancreatitis, WON size, and location. There was no difference in the technical success between the two groups (100% vs. 98.8%, P = 1), or in clinical success rates (78.7% vs. 77.9%). There was a significant difference in the required number of direct endoscopic necrosectomies to achieve clinical success in the PPI vs. non-PPI group (3.2 vs. 4.6 respectively, P < 0.01). There were significantly more cases of stent occlusion in the non-PPI group vs. PPI group (9.5% vs. 20.1% P = 0.012), but all other documented adverse events were not significantly different.

conclusionDiscontinuing PPIs during endoscopic drainage and necrosectomy of symptomatic WON appears to reduce the number of endoscopic procedures required to achieve resolution. Continuous PPI results in higher rates of early stent occlusion.

Indexed as

Direct endoscopic necrosectomyEUSlumen-apposing metal stentproton pump inhibitorwalled-off necrosis

Identifiers

PMID30719997
PMCPMC6589997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.